Is blood transfusion therapy feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts?
Blood transfusion therapy is a feasible therapy for the prevention of progression of silent cerebral infarcts.
Our results suggest that quantitative assessments of the vestibulo-ocular reflex should be conducted on patients who are evaluated for falls risk. These examinations should include at least caloric testing and, where available, rotational testing.